Experimental drug tested to slow scarring lung disease
Disease control
Completed
This study tested whether an oral drug called MN-001 could help control idiopathic pulmonary fibrosis (IPF), a serious disease that scars the lungs. Fifteen adults with moderate to severe IPF took either MN-001 or a placebo pill twice daily for six months, followed by another six…
Phase: PHASE2 • Sponsor: MediciNova • Aim: Disease control
Last updated Mar 23, 2026 15:17 UTC